AU Patent

AU2013305684B2 — Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof

Assigned to XenoPort Inc · Expires 2016-11-24 · 9y expired

What this patent protects

Improved oral dosage forms of methyl hydrogen fumarate and prodrugs thereof are disclosed. Methods of treating diseases such as multiple sclerosis and psoriasis using such dosage forms are also disclosed.

USPTO Abstract

Improved oral dosage forms of methyl hydrogen fumarate and prodrugs thereof are disclosed. Methods of treating diseases such as multiple sclerosis and psoriasis using such dosage forms are also disclosed.

Drugs covered by this patent

Patent Metadata

Patent number
AU2013305684B2
Jurisdiction
AU
Classification
—
Expires
2016-11-24
Drug substance claim
No
Drug product claim
No
Assignee
XenoPort Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.